Skip to content
DO-HEALTH > BIOBANK & DATA > Data

Data

All DO-HEALTH participants were extensively assessed and characterized at baseline and during the 3 year follow-up.

The table below shows all procedures, assessments, questionnaires performed at the different timepoints. The table can be searched and sorted. If available, the eCRF form/questionnaire itself can be downloaded by clicking on the PDF-icon*. A short legend can be found at the bottom of the table.

If you are interested in a collaboration please complete the form here.

Assessment
type
Procedure, AssessmentBaseline



on-site
Month
3,9,15,
21,27,33

ph call
Month
6,18,30


ph call
Month
12,24

on-site
Month
36

on-site
Biomarker25(OH)DXXX
QuestionnaireEQ5D-3LXXXX
QuestionnaireDiet assessment by Food Frequency QuestionnaireXX
QuestionnaireQuickDASHXXX
BiomarkerAA (PUFA)XXX
Adherence/Pill count##XX
Adverse eventsXXXX
BiomarkeralbuminXXX
Biomarkeralkaline phosphataseXXX
BiomarkerALTXXX
BiomarkerASTXXX
BiomarkerbilirubinXXX
BiomarkerBlood cell countX
examinationBlood pressureXXX
DXABody composition and fat massXXX
DXABone mineral density in the spine and hipXXX
BiomarkercalciumXXX
BiomarkerCD3**XXX
BiomarkerCD4**XXX
BiomarkerCD25**XXX
BiomarkerCD127**XXX
BiomarkerchlorideXXX
BiomarkercholesterolXXX
BiomarkerCKXXX
anamnesticCo-Medication & Non-Medication ProceduresXXXXX
anamnesticComorbiditiesXXX
BiomarkercortisolXXX
BiomarkercreatinineXXX
BiomarkerCRPXXX
anamnesticDemographic informationX
examinationdental impression*XX
BiomarkerDHA (PUFA)XXX
BiomarkerDPA (PUFA)XXX
BiomarkerEPA (PUFA)XXX
QuestionnaireFallXXXXX
anamnesticFall history X
Biomarkerfasting glucoseXXX
BiomarkerferritinXXX
Biomarkerfolic acidXXX
Questionnaire, examination, x-rayFracture healing of incident fractures++
anamnesticFracture historyX
Questionnaire, DXAFractures (non-vertebral, vertebral and hip)XXXX
BiomarkerfT3XXX
BiomarkerfT4XXX
GAITRite® PlatinumGait analyses and dual task assessmentXXX
QuestionnaireGDS (excerpt)XXX
QuestionnaireGOHAIXXX
Martin VigorimeterGrip strength XXX
BiomarkerHDL-cholesterolXXX
examinationHeight and weigthXXX
BiomarkerhomocysteineXXX
QuestionnaireHOOSXXX
Hospital admissionsXXXX
BiomarkerIL-6XXX
BiomarkerIL-10**XXX
BiomarkerIL-17**XXX
BiomarkerIL-22**XXX
Implant infections after total hip or knee replacementXXXX
Incident cancerXXXX
Incident nephrolithiasisXX
Incident symptomatic osteoarthritis (knee, hip, and hand)XXX
QuestionnaireInfectionXXXXX
BiomarkerinsulinXXX
Biomarkerintact PTHXXX
QuestionnaireJoint mapXXX
QuestionnaireKOOSXXX
BiomarkermagnesiumXXX
Major cardiovascular eventsXXXX
QuestionnaireMc Gill pain map (modified version)XXX
QuestionnaireMMSEX
QuestionnaireMoCA (Montreal Cognitive Assessment)XXX
MortalityXXXX
DXAMuscle mass in the upper and lower extremities (DXA)XXX
BiomarkermyostatinXXX
QuestionnaireNHS, excerptXXX
BiomarkerNT-proBNPXXX
Nursing home admissionsXXXX
BiomarkerP1NPXXX
BiomarkerphosphateXXX
Physical activityXXX
Physical examinationXXX
BiomarkerpotassiumXXX
QuestionnairePROMIS-HAQXXX
QuestionnaireROME IIIXXX
QuestionnaireSangha’s instrumentXXX
BiomarkersclerostinXXX
Self-reported adherence to study treatments and exercise program XXXX
QuestionnaireSHARE-FIXXX
examinationShort Physical Performance BatteryXXX
BiomarkersodiumXXX
QuestionnaireSubjective cognitive decline (Subjective memory complains)**X
Symptomatic osteoarthritis
(severity of knee pain, knee buckling, total number of joints with pain, and NSAID use)
XXX
BiomarkerTNF-α**XXX
examinationTooth countXXX
Biomarkertotal proteinXXX
BiomarkertransferrinXXX
BiomarkertriglyceridesXXX
BiomarkerTroponin-TXXX
BiomarkerTSHXXX
BiomarkerureaXXX
Biomarkeruric acidXXX
Biomarkerurinary calcium/creatinine ratio (second spot urine)XXX
Biomarkervitamin B12XXX
Biomarkerβ-crosslapsXXX
Biomarkerγ-GTXXX
QuestionnaireKneeBucklingXXX
QuestionnaireParticipantSatisfactionXX
QuestionnaireSunlightExposureXXX
on-site = clinical on-site visit; ph call = phone call visit
* 100 participants at site Zürich at baseline and 12 month visit only
** Assessed in 802 participants at two study centers Zurich and Basel
† Measurement taken in 1502 participants at four study centers equipped with iDXA machines.
‡ Measurement taken in 250 seniors recruited at Basel University Hospital.
##Pill count also performed outside clinical visits when required.
++ assessed only in individuals with incident major osteoporotic fractures at the arm (shoulder, humerus, forearm) and leg (hip, femur, ankle): PROMIS-HAQ at 6, 12, 18 weeks after the fracture; SPPB and grip strength at 12, 24 and 36 months; independent/external x-ray at 6-8 weeks and 12 to 14 weeks after the fracture, if available